Horizon Finance (HRZN) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
3 Feb, 2026Executive summary
Announced a strategic merger between MRCC and HRZN, with MRCC selling its portfolio to MCIP and merging into HRZN via a NAV-for-NAV share exchange, creating a larger, scalable BDC platform with enhanced scale and operational efficiencies.
The transaction is structured in two steps, resulting in a $165 million equity infusion for HRZN and a pro forma NAV of approximately $446 million.
MRCC shareholders receive a 33% NAV premium to trading price and a tax-free HRZN share exchange, unlocking immediate and long-term value.
The merger is expected to close in December 2025, pending regulatory and shareholder approvals.
Net asset value per share declined to $6.75 as of June 30, 2025, reflecting realized and unrealized losses on investments.
Financial highlights
Combined company estimated NAV will be approximately $446 million post-merger, with MRCC shareholders owning about 37%.
MRCC asset sale at estimated NAV of $8.27–$8.31 per share, a 33% premium to the $6.21 trading price as of August 5, 2025.
Net investment income for Q2 2025 was $11.4 million ($0.28 per share), down from $12.9 million ($0.36 per share) in Q2 2024.
$2.5 million in annual G&A expense savings expected, reducing combined G&A from $8.4 million to $5.8 million.
Dollar-weighted annualized yield on debt investments was 15.8% for Q2 2025, consistent with the prior year.
Outlook and guidance
Merger expected to be neutral to core net investment income in year one and accretive over time, driven by cost savings, portfolio optimization, and access to lower-cost financing.
Management anticipates rapid capital deployment post-merger, aiming for EPS neutrality in the first year.
Board declared monthly distributions of $0.11 per share for July, August, and September 2025, and regular monthly distributions totaling $0.33 per share through December 2025.
Management expects current cash, operations, and credit facilities to be sufficient for at least the next 12 months.
Focus remains on navigating a challenging venture capital environment and positioning for growth in 2026.
Latest events from Horizon Finance
- Supplemental distributions proposed to enhance shareholder value amid merger approval process.HRZN
Proxy Filing11 Mar 2026 - Portfolio growth resumed in Q4, with strong yields and a transformative merger ahead.HRZN
Q4 20254 Mar 2026 - NII and NAV fell, but 15.9% yield and strong liquidity support H2 2024 growth outlook.HRZN
Q2 20242 Feb 2026 - Net investment income fell, but portfolio growth and strong liquidity supported distributions.HRZN
Q3 202417 Jan 2026 - NII covered distributions in 2024, but NAV fell; strong yield and liquidity support 2025 growth.HRZN
Q4 202425 Dec 2025 - Vote sought on new investment management agreement; Board recommends approval for continuity.HRZN
Proxy Filing1 Dec 2025 - Shareholders will vote on director elections and auditor ratification, with robust governance in place.HRZN
Proxy Filing1 Dec 2025 - Shareholders to vote on a new investment management agreement after adviser's change in control.HRZN
Proxy Filing1 Dec 2025 - Vote on a new investment management agreement is urged following a change in adviser control.HRZN
Proxy Filing1 Dec 2025